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Bisphenol A Diglycidyl Ether
as a Potential Metabolic
Source of Bisphenol A
Epoxy resins find widespread use as adhesives
and coatings in the construction and food
industries. The majority of the products are
based on resins that use bisphenol A digly-
cidyl ether (BADGE) as a precursor. This
raises the question if BADGE could be a
potential source ofbisphenol A (BPA).
The recent paper by Perez et al. (1) on the
estrogenicity of BPA and some of its analogs
and derivatives states that little is known
about the disposition and metabolism of this
compound in mammals. In fact, preliminary
reports ofits fate in rats have been published
in abstract form (2,3). In searching for infor-
mation on the metabolism of BPA and its
derivatives, the authors identified our papers
on the fate of BADGE in mice (4,5). These
papers were based on a thorough study ofthe
metabolism of [14C]BADGE in which most
ofthe metabolites were identified. The objec-
tives of the study were twofold: to describe
the overall fate of BADGE and to assess the
amount of O-dealkylation to either glyci-
daldehyde (a bacterial mutagen) or to glycer-
aldehyde (relatively innocuous). Because the
14C-glycidyl label was not available to us, we
hoped to use the yield of BPA (and its pro-
posed glucuronide and sulfate conjugates) as
indicators ofthe generation ofglycidaldehyde.
To our surprise, BPA could not be con-
firmed as a metabolite of BADGE. BADGE
afforded six metabolites (and three conju-
gates), mostly novel, which accounted for
1-24% of the dose. These were formed by
hydrolytic and glutathione-dependent open-
ing of the epoxide rings. Further metabolism
of the products occurred by oxidation and
decarboxylation. Loss of one glycidyl group
could be confirmed (1-3%) ofthe dose. The
only evidence for the presence ofBPA was in
a neutral solvent extract of feces. This frac-
tion (0.1% ofthe dose) was subjected to fur-
ther chromatographic analysis and a small
proportion, well under 0.1% of the dose,
may have been BPA. This could not be con-
firmed. When BADGE bis-diol was dosed to
mice, no BPA could be detected.
Further attempts were made to demon-
strate deglycidylation (and BPA production)
using liver microsomes from mouse, rat, and
rabbit, operating in an oxidative mode. Even
inhibiting epoxide hydrase with trichloro-
methyloxirane, no BPA could be detected.
Citing our papers (4,5), Perez et al. (1)
state that "a small amount ofBADGE (-5%)
underwent oxidative dealkylation to give gly-
cidaldehyde (which has alkylating properties)
and BPA." Our studies showed that only
traces (<<0.1%) of a metabolite which may
have been BPA were formed from BADGE.
Thus, the available evidence shows that
BADGE is not a significant metabolic source
ofbisphenol A.
D.H. Hutson
Falmouth, Cornwall, United Kingdom
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Co cons and Clarfications
In the commentary byBoerrger-Tong et al.
(A Case ofa LaboratoryAnimal Feed with
High EstronicActivityand ItsImpact on
in: VMiv Response.s to Exogenously
AdMmiiserd Esops) blished in EMP
[iO6:369-.~373 (1998)], the..didzen conte.nt.
:in feed ws incorrect in:the abstract; the
*. correct..content .of daiden: in feed is 140:o
rng/k& ..
Draft technical reports of the National Toxicology Program two-year studies listed below are available
for public review and commenton the EHIS Web site forf . These reports are tentatively scheduled
toundergo peer review on October 30.
* Ethylene glycol monobutyl ether-used as a solvent for mineral oils
in spraylacquers,vamish removers,and metal cleaners
* Glutaraldehyde-used as a disinfectant and sterilizing agent, and in
adhesives, electrical products, dental materials, tanning of leathers, and
photographicdeveloping
* Methyleugenol-used as an insectaltrctantand as a maiorconstituent
ofcloveoil,which is used in spices, perfumes, and favorings
* Oxymetholone-used to promote weight gain and in the treatment of
debilitafing diseases, serious infections, bums, trauma,andanemia
* Triethanolamine-used in themanufactureofsurfactants, textiles,waxes,
polishes, herbicides, toiletgoods,oilemulsions, and pharmaceuticals
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